News

Intas Pharmaceuticals has received approval from the Subject Expert Committee (SEC), functioning under the Central Drugs ...
China NMPA accepts Hutchmed & Innovent’s NDA for fruquintinib in combo with sintilimab to treat advanced renal cell carcinoma: Hong Kong, Shanghai Friday, June 6, 2025, 09:00 Hr ...
and it is probable that direct tyrosine phosphorylation of voltage-activated sodium channels underlies the previously observed effects of src kinase and ras activation 6. Transient co-expression ...
Growth of Kym-1 rhabdomyosarcoma cells depends on endogenous receptor tyrosine kinase signals activated by insulin and insulin-like growth factors (IGF), as revealed from enhancement of ...
Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...
This next-generation ROS1 tyrosine kinase inhibitor previously received breakthrough therapy and orphan drug designations for ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Jaipur: Supporting RAS mains aspirants, Akhil Bharatiya Vidyarthi Parishad (ABVP) joined the protest on Thursday with the demand that the exam should be postponed. The exam is scheduled to take ...
The FDA approved taletrectinib for ROS1-positive NSCLC. The agent shows efficacy for both new and pretreated cases, including ...
Ras Kronik takes the remix route on two of his songs, which will be released in June. Both are done by Steve “Mr Mig” Migliore, who has worked with major acts like Beyonce and Taylor Swift.